Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 979735321000036112 | Clarinase Repetab modified release tablet, 14 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 979735341000036116 | Clarinase Repetab (loratadine 5 mg + pseudoephedrine sulfate 120 mg) modified release tablet, 14 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Clarinase Repetab modified release tablet, 14 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Clarinase Repetab modified release tablet, 14 | Is a | loratadine 5 mg + pseudoephedrine sulfate 120 mg modified release tablet, 14 | true | Inferred relationship | Some | ||
| Clarinase Repetab modified release tablet, 14 | has TPUU | Clarinase Repetab modified release tablet | true | Inferred relationship | Some | 1 | |
| Clarinase Repetab modified release tablet, 14 | has TP | Clarinase Repetab | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Clarinase Repetab modified release tablet, 14, blister pack | Is a | True | Clarinase Repetab modified release tablet, 14 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR